Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Hirsutism causes significant psychological distress in women.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Extra virgin olive oil may boost the immune system and help fight infections like COVID-19.

New nano composite helps reduce scars and regrow hair during burn wound healing.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Finasteride can cause sexual dysfunction and depression, which may persist and require hormonal treatment.

Finasteride can cause sexual dysfunction, sperm changes, and affect bone density and metabolism.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

AGA in children needs careful diagnosis due to low androgen levels and possible other causes.

Some sports supplements can cause health issues like mood swings, hair loss, and heart problems in men.

Finasteride-loaded ethosomes improve hair loss treatment by targeting pilosebaceous unit.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.